Inventor
Karl A. Scheidt
Inventor
Evanston, IL, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
A61KPreparations for medical, dental or toiletry purposes12%
C07BGeneral methods of organic chemistry9%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry5%
C07CAcyclic or carbocyclic compounds5%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds2%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2%
PatentTitleYear
10,780,076Inhibition of cancer cell motility202010,781,172Catalysts and methods for enantioselective conjugate additions of amines to unsaturated electrophiles202010,654,865Enantioselective syntheses of heteroyohimbine natural product intermediates202010,323,039Enantioselective syntheses of heteroyohimbine natural product intermediates201910,308,624Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds201910,231,949Inhibition of cancer cell motility20199,981,968Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders20189,840,487'Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds'20179,839,625'Inhibition of cancer cell motility'20179,643,947'7-membered fused heterocycles and methods of their synthesis'20179,624,190'Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds'20179,527,812'N-heterocyclic carbene-catalyzed synthesis of 2-aryl indoles'20169,512,146'Azolium metal-organic frameworks'20169,334,297'Chiral imidazolium salts for asymmetric catalysis'20169,309,217'Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds'20169,260,564'Catalyst for non-isocyanate based polyurethane'20169,090,634'Azolium metal-organic frameworks'20158,912,341'Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinones'20148,742,141'Inhibition and treatment of prostate cancer metastasis'20148,481,760'Inhibition and treatment of prostate cancer metastasis'20137,851,640'Catalytic enantioselective synthesis of flavanones and chromanones'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2020Patents assigned to UNIV NORTHWESTERN (21)· patent assignee history
2010–2020Based in Evanston, IL, US· patent location history
2013–2015Patents assigned to SCHEIDT KARL A (2)· patent assignee history
2013Patents assigned to BERGAN RAYMOND C (1)· patent assignee history
2015Patents assigned to FARHA OMAR K (1)· patent assignee history
2016Patents assigned to DOW GLOBAL TECHNOLOGIES LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV NORTHWESTERN | 21 | 2010–2020 |
| SCHEIDT KARL Aself | 2 | 2013–2015 |
| BERGAN RAYMOND C | 1 | 2013 |
| DOW GLOBAL TECHNOLOGIES LLC | 1 | 2016 |
| FARHA OMAR K | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Evanston, Illinois, US | 21 | 2010–2020 |